Review



c1 microfluidics based platform  (fluidigm)


Bioz Verified Symbol fluidigm is a verified supplier
Bioz Manufacturer Symbol fluidigm manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    fluidigm c1 microfluidics based platform
    C1 Microfluidics Based Platform, supplied by fluidigm, used in various techniques. Bioz Stars score: 96/100, based on 3404 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c1 microfluidics based platform/product/fluidigm
    Average 96 stars, based on 3404 article reviews
    c1 microfluidics based platform - by Bioz Stars, 2026-02
    96/100 stars

    Images



    Similar Products

    96
    fluidigm c1 microfluidics based platform
    C1 Microfluidics Based Platform, supplied by fluidigm, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c1 microfluidics based platform/product/fluidigm
    Average 96 stars, based on 1 article reviews
    c1 microfluidics based platform - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    90
    fluidigm microfluidics-based platform
    Microfluidics Based Platform, supplied by fluidigm, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/microfluidics-based platform/product/fluidigm
    Average 90 stars, based on 1 article reviews
    microfluidics-based platform - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Mission Bio microfluidic-based encapsulation platform
    Microfluidic Based Encapsulation Platform, supplied by Mission Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/microfluidic-based encapsulation platform/product/Mission Bio
    Average 90 stars, based on 1 article reviews
    microfluidic-based encapsulation platform - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Biofluids Inc porous membrane based microfluidic platforms
    <t> Microfluidic-based </t> studies for biomolecular detection
    Porous Membrane Based Microfluidic Platforms, supplied by Biofluids Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/porous membrane based microfluidic platforms/product/Biofluids Inc
    Average 90 stars, based on 1 article reviews
    porous membrane based microfluidic platforms - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Bruker Corporation microfluidics-based multiplexed lab-on-chip proteomics assay platform isolight
    <t>IsoLight</t> single T-cell live functional immune proteomics profiling workflow.
    Microfluidics Based Multiplexed Lab On Chip Proteomics Assay Platform Isolight, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/microfluidics-based multiplexed lab-on-chip proteomics assay platform isolight/product/Bruker Corporation
    Average 90 stars, based on 1 article reviews
    microfluidics-based multiplexed lab-on-chip proteomics assay platform isolight - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    10X Genomics microfluidic droplet-based platform 10x genomics chromium
    A) Comparison of SAFAARI’s performance with the selected reference-based cell-type annotation models in both open-set and closed-set settings. The scRNA-seq data from eight different tissues in the Tabula Muris cell atlas was obtained where the gene counts were derived using two techniques: 10x Genomics and FACS-based cell capture in plates (FACS). For the performance assessment, either FACS or 10x was considered as the source dataset, and the other as the target dataset, to evaluate reference-based cell type annotation or label transfer in the presence of a technology-based domain-shift or batch effect. Two scenarios were considered: the closed-set, where only cell types common to both source and target datasets were included, and the open-set, where the target dataset contained an unknown cell type not present in the source dataset . B) Heatmap representing the confusion matrix across eight tissues (target: FACS), showing cell-type-specific annotation performance. Columns represent the actual cell labels, while rows show the predicted cell labels. The cell type coloured in navy blue represents the unknown cell type whose instances were removed from the source dataset. Colours in the viridis palette and indicate the proportion of cells relative to the sum of the column (i.e., values across columns should add up to 1.0). This represents the proportion of correct classifications (diagonal values) and misclassifications for each particular cell type represented by the column names. C) UMAP of open-set Label transfer result of SAFAARI on four human pancreas datasets generated with different technologies, including <t>microfluidic</t> (Fluidigm C), droplet-based (InDrops) and plate-based scRNA-seq (CEL-seq2, Smart-seq2) as detailed in . It demonstrates SAFAARI’s superior batch mixing, cell separation and unknown cell type detection.
    Microfluidic Droplet Based Platform 10x Genomics Chromium, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/microfluidic droplet-based platform 10x genomics chromium/product/10X Genomics
    Average 90 stars, based on 1 article reviews
    microfluidic droplet-based platform 10x genomics chromium - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    MicroFluidic Systems microfluidic-based platforms
    A) Comparison of SAFAARI’s performance with the selected reference-based cell-type annotation models in both open-set and closed-set settings. The scRNA-seq data from eight different tissues in the Tabula Muris cell atlas was obtained where the gene counts were derived using two techniques: 10x Genomics and FACS-based cell capture in plates (FACS). For the performance assessment, either FACS or 10x was considered as the source dataset, and the other as the target dataset, to evaluate reference-based cell type annotation or label transfer in the presence of a technology-based domain-shift or batch effect. Two scenarios were considered: the closed-set, where only cell types common to both source and target datasets were included, and the open-set, where the target dataset contained an unknown cell type not present in the source dataset . B) Heatmap representing the confusion matrix across eight tissues (target: FACS), showing cell-type-specific annotation performance. Columns represent the actual cell labels, while rows show the predicted cell labels. The cell type coloured in navy blue represents the unknown cell type whose instances were removed from the source dataset. Colours in the viridis palette and indicate the proportion of cells relative to the sum of the column (i.e., values across columns should add up to 1.0). This represents the proportion of correct classifications (diagonal values) and misclassifications for each particular cell type represented by the column names. C) UMAP of open-set Label transfer result of SAFAARI on four human pancreas datasets generated with different technologies, including <t>microfluidic</t> (Fluidigm C), droplet-based (InDrops) and plate-based scRNA-seq (CEL-seq2, Smart-seq2) as detailed in . It demonstrates SAFAARI’s superior batch mixing, cell separation and unknown cell type detection.
    Microfluidic Based Platforms, supplied by MicroFluidic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/microfluidic-based platforms/product/MicroFluidic Systems
    Average 90 stars, based on 1 article reviews
    microfluidic-based platforms - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Cynvenio Biosystems Inc liquidbiopsy epcam-based microfluidic ctc capture platform
    A) Comparison of SAFAARI’s performance with the selected reference-based cell-type annotation models in both open-set and closed-set settings. The scRNA-seq data from eight different tissues in the Tabula Muris cell atlas was obtained where the gene counts were derived using two techniques: 10x Genomics and FACS-based cell capture in plates (FACS). For the performance assessment, either FACS or 10x was considered as the source dataset, and the other as the target dataset, to evaluate reference-based cell type annotation or label transfer in the presence of a technology-based domain-shift or batch effect. Two scenarios were considered: the closed-set, where only cell types common to both source and target datasets were included, and the open-set, where the target dataset contained an unknown cell type not present in the source dataset . B) Heatmap representing the confusion matrix across eight tissues (target: FACS), showing cell-type-specific annotation performance. Columns represent the actual cell labels, while rows show the predicted cell labels. The cell type coloured in navy blue represents the unknown cell type whose instances were removed from the source dataset. Colours in the viridis palette and indicate the proportion of cells relative to the sum of the column (i.e., values across columns should add up to 1.0). This represents the proportion of correct classifications (diagonal values) and misclassifications for each particular cell type represented by the column names. C) UMAP of open-set Label transfer result of SAFAARI on four human pancreas datasets generated with different technologies, including <t>microfluidic</t> (Fluidigm C), droplet-based (InDrops) and plate-based scRNA-seq (CEL-seq2, Smart-seq2) as detailed in . It demonstrates SAFAARI’s superior batch mixing, cell separation and unknown cell type detection.
    Liquidbiopsy Epcam Based Microfluidic Ctc Capture Platform, supplied by Cynvenio Biosystems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/liquidbiopsy epcam-based microfluidic ctc capture platform/product/Cynvenio Biosystems Inc
    Average 90 stars, based on 1 article reviews
    liquidbiopsy epcam-based microfluidic ctc capture platform - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Qiagen qiacuity nanoplate-based microfluidic dpcr platform
    A) Comparison of SAFAARI’s performance with the selected reference-based cell-type annotation models in both open-set and closed-set settings. The scRNA-seq data from eight different tissues in the Tabula Muris cell atlas was obtained where the gene counts were derived using two techniques: 10x Genomics and FACS-based cell capture in plates (FACS). For the performance assessment, either FACS or 10x was considered as the source dataset, and the other as the target dataset, to evaluate reference-based cell type annotation or label transfer in the presence of a technology-based domain-shift or batch effect. Two scenarios were considered: the closed-set, where only cell types common to both source and target datasets were included, and the open-set, where the target dataset contained an unknown cell type not present in the source dataset . B) Heatmap representing the confusion matrix across eight tissues (target: FACS), showing cell-type-specific annotation performance. Columns represent the actual cell labels, while rows show the predicted cell labels. The cell type coloured in navy blue represents the unknown cell type whose instances were removed from the source dataset. Colours in the viridis palette and indicate the proportion of cells relative to the sum of the column (i.e., values across columns should add up to 1.0). This represents the proportion of correct classifications (diagonal values) and misclassifications for each particular cell type represented by the column names. C) UMAP of open-set Label transfer result of SAFAARI on four human pancreas datasets generated with different technologies, including <t>microfluidic</t> (Fluidigm C), droplet-based (InDrops) and plate-based scRNA-seq (CEL-seq2, Smart-seq2) as detailed in . It demonstrates SAFAARI’s superior batch mixing, cell separation and unknown cell type detection.
    Qiacuity Nanoplate Based Microfluidic Dpcr Platform, supplied by Qiagen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/qiacuity nanoplate-based microfluidic dpcr platform/product/Qiagen
    Average 90 stars, based on 1 article reviews
    qiacuity nanoplate-based microfluidic dpcr platform - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


     Microfluidic-based  studies for biomolecular detection

    Journal: BioImpacts : BI

    Article Title: Microfluidics as a promising technology for personalized medicine

    doi: 10.34172/bi.29944

    Figure Lengend Snippet: Microfluidic-based studies for biomolecular detection

    Article Snippet: Porous membrane based microfluidic platforms also can simply separate microvesicles from biofluids.

    Techniques: Amplification, Labeling, Isolation, Binding Assay, Hybridization, SPR Assay, Control

     Microfluidic-based  studies for drug screening

    Journal: BioImpacts : BI

    Article Title: Microfluidics as a promising technology for personalized medicine

    doi: 10.34172/bi.29944

    Figure Lengend Snippet: Microfluidic-based studies for drug screening

    Article Snippet: Porous membrane based microfluidic platforms also can simply separate microvesicles from biofluids.

    Techniques: Isolation, Drug discovery, Microscopy

    Cancer on a chip studies

    Journal: BioImpacts : BI

    Article Title: Microfluidics as a promising technology for personalized medicine

    doi: 10.34172/bi.29944

    Figure Lengend Snippet: Cancer on a chip studies

    Article Snippet: Porous membrane based microfluidic platforms also can simply separate microvesicles from biofluids.

    Techniques: Membrane, Cell Culture, Activation Assay, In Vitro, Shear

    Organ-on-a -chip studies

    Journal: BioImpacts : BI

    Article Title: Microfluidics as a promising technology for personalized medicine

    doi: 10.34172/bi.29944

    Figure Lengend Snippet: Organ-on-a -chip studies

    Article Snippet: Porous membrane based microfluidic platforms also can simply separate microvesicles from biofluids.

    Techniques: Cell Culture, Diffusion-based Assay, Shear, Functional Assay, Membrane, Construct, Derivative Assay, Generated, Polymer, Fluorescence

    IsoLight single T-cell live functional immune proteomics profiling workflow.

    Journal: Translational Lung Cancer Research

    Article Title: Quantitative peripheral live single T-cell dynamic polyfunctionality profiling predicts lung cancer checkpoint immunotherapy treatment response and clinical outcomes

    doi: 10.21037/tlcr-24-260

    Figure Lengend Snippet: IsoLight single T-cell live functional immune proteomics profiling workflow.

    Article Snippet: In this proof-of-concept analysis, we adopted a microfluidics-based multiplexed lab-on-chip proteomics assay platform, IsoLight (Bruker Cellular Analysis, Branford, CT, USA; formerly IsoPlexis), to functionally interrogate live peripheral T-lymphocyte subsets at the single-cell level in a discovery study of T-lymphocytes polyfunctionality as a potential predictive biomarker for ICI treatment response and clinical outcomes correlation in NSCLC.

    Techniques: Functional Assay

    A) Comparison of SAFAARI’s performance with the selected reference-based cell-type annotation models in both open-set and closed-set settings. The scRNA-seq data from eight different tissues in the Tabula Muris cell atlas was obtained where the gene counts were derived using two techniques: 10x Genomics and FACS-based cell capture in plates (FACS). For the performance assessment, either FACS or 10x was considered as the source dataset, and the other as the target dataset, to evaluate reference-based cell type annotation or label transfer in the presence of a technology-based domain-shift or batch effect. Two scenarios were considered: the closed-set, where only cell types common to both source and target datasets were included, and the open-set, where the target dataset contained an unknown cell type not present in the source dataset . B) Heatmap representing the confusion matrix across eight tissues (target: FACS), showing cell-type-specific annotation performance. Columns represent the actual cell labels, while rows show the predicted cell labels. The cell type coloured in navy blue represents the unknown cell type whose instances were removed from the source dataset. Colours in the viridis palette and indicate the proportion of cells relative to the sum of the column (i.e., values across columns should add up to 1.0). This represents the proportion of correct classifications (diagonal values) and misclassifications for each particular cell type represented by the column names. C) UMAP of open-set Label transfer result of SAFAARI on four human pancreas datasets generated with different technologies, including microfluidic (Fluidigm C), droplet-based (InDrops) and plate-based scRNA-seq (CEL-seq2, Smart-seq2) as detailed in . It demonstrates SAFAARI’s superior batch mixing, cell separation and unknown cell type detection.

    Journal: bioRxiv

    Article Title: Single-Cell Data Integration and Cell Type Annotation through Contrastive Adversarial Open-set Domain Adaptation

    doi: 10.1101/2024.10.04.616599

    Figure Lengend Snippet: A) Comparison of SAFAARI’s performance with the selected reference-based cell-type annotation models in both open-set and closed-set settings. The scRNA-seq data from eight different tissues in the Tabula Muris cell atlas was obtained where the gene counts were derived using two techniques: 10x Genomics and FACS-based cell capture in plates (FACS). For the performance assessment, either FACS or 10x was considered as the source dataset, and the other as the target dataset, to evaluate reference-based cell type annotation or label transfer in the presence of a technology-based domain-shift or batch effect. Two scenarios were considered: the closed-set, where only cell types common to both source and target datasets were included, and the open-set, where the target dataset contained an unknown cell type not present in the source dataset . B) Heatmap representing the confusion matrix across eight tissues (target: FACS), showing cell-type-specific annotation performance. Columns represent the actual cell labels, while rows show the predicted cell labels. The cell type coloured in navy blue represents the unknown cell type whose instances were removed from the source dataset. Colours in the viridis palette and indicate the proportion of cells relative to the sum of the column (i.e., values across columns should add up to 1.0). This represents the proportion of correct classifications (diagonal values) and misclassifications for each particular cell type represented by the column names. C) UMAP of open-set Label transfer result of SAFAARI on four human pancreas datasets generated with different technologies, including microfluidic (Fluidigm C), droplet-based (InDrops) and plate-based scRNA-seq (CEL-seq2, Smart-seq2) as detailed in . It demonstrates SAFAARI’s superior batch mixing, cell separation and unknown cell type detection.

    Article Snippet: These methods range from microfluidic droplet-based platforms (such as 10x Genomics Chromium, Drop-seq, and inDrops) to plate-based scRNA-seq technologies like Smart-seq, Smart-seq2, and Smart-seq3, resulting in substantial heterogeneity across datasets.

    Techniques: Comparison, Derivative Assay, Generated